RE:RE:RE:RE:Poor top and bottom-line with low and shirking margins. Nice back and forth. Overall while Punjabi makes some very respectable points they are succinctly black and white and not at all accounting for the time needed to grow/absorb and build scale. As KC points out, applying a generalized cannabis company template toward Valens and coming to such immediately negative conclusions is missing many very important internal and external factors, which weighed down top and bottom line numbers. Admittedly the current margin profile is absolutely awful and by Q4 it should hopefully be a rather unfortunate distant memory and if that's not the case, my shares will probably be up for sale.